beta2-microglobulin

β2-mi·cro·glob·u·lin

the light chain, of the histocompatibility class I molecule, found in elevated levels in patients with Wilson disease and in alcohol-induced liver cirrhosis; the human protein consists of 99 amino acyl residues and has a molecular weight of 11.8 kDa.
References in periodicals archive ?
013) and a decrease in the urinary albumin/creatinine ratio and the serum beta2-microglobulin level (p = 0.
The subject of the public tender will supply of reagents and consumables for the determination of biochemical parameters turbidimetry system: free kappa light chains in serum, urine and cerebrospinal fluid, lambda free light chains in serum, urine and cerebrospinal fluid and beta2-microglobulin in serum associated with the borrowing required equipment for the Department of Laboratory Diagnostics and Department of Clinical Biochemistry, University Hospital Ostrava.
The test utilizes five well-established biomarkers -- Transthyretin (TT or prealbumin), Apolipoprotein A-1 (Apo A-1), Beta2-Microglobulin (Beta2M), Transferrin (Tfr) and Cancer Antigen 125 (CA 125 II) -- and proprietary software to determine the likelihood of malignancy in women with an ovarian mass for whom surgery is planned.
Beta2-microglobulin (BMG) is a low-molecular-mass (11.
The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression.
Dose-response relationship between urinary cadmium and beta2-microglobulin in a Japanese environmentally cadmium exposed population.
Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations.
Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
The successful "take" of yellow fever vaccine can be determined starting the second postvaccination day by demonstrable viremia detected by reverse-transcriptase polymerase chain reaction and by marked increases in neopterin, beta2-microglobulin, and circulating CD[8.
The test utilizes five well-established biomarkers Transthyretin (TT or prealbumin), Apolipoprotein A-1 (Apo A-1), Beta2-Microglobulin (Beta2M), Transferrin (Tfr) and Cancer Antigen 125 (CA 125 II) -- and a proprietary algorithm to determine the likelihood of malignancy in women with pelvic mass for whom surgery is planned.
The test utilizes five well-established biomarkers -- Transthyretin (TT or prealbumin), Apolipoprotein A-1 (Apo A-1), Beta2-Microglobulin (Beta2M), Transferrin (Tfr) and Cancer Antigen 125 (CA 125 II) -- and a proprietary algorithm to determine the likelihood of malignancy in women with pelvic mass for whom surgery is planned.